This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Latvian Institute of Organic Synthesis. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Jelena Vasiljeva: Innovator in Pharmaceutical Chemistry
Introduction
Jelena Vasiljeva is a prominent inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, her work focuses on innovative solutions for treating various diseases.
Latest Patents
Jelena's latest patents include "Selenophenochromene hydroxamic acids, preparation and use as angiogenesis inhibitors." This invention relates to novel selenophenochromene hydroxamic acids that serve as angiogenesis inhibitors. The methods of manufacturing and using these substances are aimed at treating or preventing various diseases and disorders. Another significant patent is "Antimetastatic 2H-selenopheno[3,2-h]chromenes, synthesis thereof, and methods of using same agents." This invention focuses on cancer metastasis prevention and treatment through the development of selenopheno[h]chromene derivatives.
Career Highlights
Jelena Vasiljeva is affiliated with the Latvian Institute of Organic Synthesis, where she conducts her research and development work. Her innovative approach and dedication to her field have positioned her as a key figure in pharmaceutical research.
Collaborations
Throughout her career, Jelena has collaborated with notable colleagues, including Pavels Arsenjans and Ilona Domraceva. These partnerships have enhanced her research efforts and contributed to the advancement of her projects.
Conclusion
Jelena Vasiljeva's contributions to pharmaceutical chemistry through her innovative patents highlight her role as a leading inventor in her field. Her work continues to pave the way for new treatments and advancements in medical science.